Janus Henderson Group PLC Guardant Health, Inc. Transaction History

Janus Henderson Group PLC

$194 Billion
Q2 2025

A detailed history of Janus Henderson Group PLC transactions in Guardant Health, Inc. stock. As of the latest transaction made, Janus Henderson Group PLC holds 71,885 shares of GH stock, worth $5.05 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

71,885

Previous 56,678 26.83%

Holding current value

$5.05 Million

Previous $2.41 Million 54.93%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	BUY	$37.05 - $52.04 $563,419 - $791,372	15,207 Added 26.83%	71,885 $3.74 Million
Q4 2024 Feb 14, 2025	SELL	$20.2 - $38.11 $78,780 - $148,629	-3,900 Reduced 6.44%	56,678 $1.73 Million
Q3 2024 Nov 14, 2024	BUY	$22.3 - $36.29 $188,033 - $305,997	8,432 Added 16.17%	60,578 $1.39 Million
Q2 2024 Aug 14, 2024	SELL	$16.07 - $31.84 $9,690 - $19,199	-603 Reduced 1.14%	52,146 $1.51 Million
Q1 2024 May 15, 2024	BUY	$17.13 - $26.91 $342 - $538	20 Added 0.04%	52,749 $1.09 Million
Q4 2023 Feb 14, 2024	SELL	$21.58 - $29.5 $1,899 - $2,596	-88 Reduced 0.17%	52,729 $1.43 Million
Q3 2023 Nov 14, 2023	BUY	$25.8 - $39.97 $2,373 - $3,677	92 Added 0.17%	52,817 $1.57 Million
Q2 2023 Aug 14, 2023	BUY	$20.94 - $38.01 $304,614 - $552,931	14,547 Added 38.1%	52,725 $1.89 Million
Q1 2023 May 15, 2023	BUY	$22.92 - $33.76 $427,710 - $629,995	18,661 Added 95.61%	38,178 $894,000
Q4 2022 Feb 14, 2023	BUY	$25.44 - $59.78 $53,398 - $125,478	2,099 Added 12.05%	19,517 $530,000
Q3 2022 Nov 14, 2022	BUY	$43.66 - $61.0 $785 - $1,098	18 Added 0.1%	17,418 $937,000
Q2 2022 Aug 15, 2022	SELL	$28.82 - $77.35 $2.72 Million - $7.31 Million	-94,548 Reduced 84.46%	17,400 $702,000
Q1 2022 May 16, 2022	BUY	$48.25 - $100.49 $890,309 - $1.85 Million	18,452 Added 19.74%	111,948 $7.42 Million
Q4 2021 Feb 14, 2022	BUY	$88.71 - $120.43 $3.43 Million - $4.66 Million	38,673 Added 70.54%	93,496 $9.35 Million
Q3 2021 Nov 16, 2021	SELL	$98.77 - $132.17 $9.8 Million - $13.1 Million	-99,210 Reduced 64.41%	54,823 $6.85 Million
Q2 2021 Aug 16, 2021	SELL	$109.77 - $165.68 $9.09 Million - $13.7 Million	-82,829 Reduced 34.97%	154,033 $19.1 Million
Q1 2021 May 17, 2021	BUY	$127.04 - $179.1 $1.9 Million - $2.67 Million	14,919 Added 6.72%	236,862 $36.2 Million
Q4 2020 Feb 16, 2021	BUY	$99.96 - $135.93 $14.9 Million - $20.3 Million	149,171 Added 204.98%	221,943 $28.6 Million
Q3 2020 Nov 16, 2020	BUY	$80.32 - $111.8 $5.85 Million - $8.14 Million	72,772 New	72,772 $8.13 Million

Others Institutions Holding GH

# of Institutions

425

Shares Held

125M

Call Options Held

1.51M

Put Options Held

2.35M

View Full List

About Guardant Health, Inc.

Ticker GH
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 102,220,000
Market Cap $7.18B
Description
Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...

More about GH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Janus Henderson Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Janus Henderson Group PLC with notifications on news.

Account

Janus Henderson Group PLC Guardant Health, Inc. Transaction History